Astera Labs, Inc. (NASDAQ:ALAB) Receives $192.89 Average PT from Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has been given a consensus recommendation of “Moderate Buy” by the twenty-one ratings firms that are presently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $192.8889.

ALAB has been the topic of several research analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Barclays set a $165.00 price target on Astera Labs in a research report on Thursday, January 15th. BNP Paribas Exane started coverage on shares of Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating on the stock. Citigroup reduced their target price on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. Finally, Roth Mkm raised their price target on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th.

Astera Labs Price Performance

Shares of ALAB stock opened at $128.24 on Thursday. Astera Labs has a 1-year low of $47.13 and a 1-year high of $262.90. The company has a market cap of $21.66 billion, a price-to-earnings ratio of 105.11, a PEG ratio of 2.55 and a beta of 1.51. The stock has a 50 day simple moving average of $160.09 and a 200-day simple moving average of $174.03.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm’s revenue was up 91.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts anticipate that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 94,971 shares of Astera Labs stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. This trade represents a 5.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Philip Mazzara sold 4,849 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.80, for a total value of $600,306.20. Following the completion of the sale, the general counsel owned 138,084 shares of the company’s stock, valued at approximately $17,094,799.20. The trade was a 3.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 389,792 shares of company stock worth $56,013,809. 12.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Compound Planning Inc. increased its position in Astera Labs by 98.3% during the fourth quarter. Compound Planning Inc. now owns 2,766 shares of the company’s stock worth $460,000 after purchasing an additional 1,371 shares during the last quarter. Corient Private Wealth LLC grew its stake in shares of Astera Labs by 1,335.8% in the 4th quarter. Corient Private Wealth LLC now owns 88,660 shares of the company’s stock valued at $14,749,000 after buying an additional 82,485 shares during the period. Alberta Investment Management Corp purchased a new stake in shares of Astera Labs in the 4th quarter valued at approximately $4,641,000. Mercer Global Advisors Inc. ADV increased its holdings in shares of Astera Labs by 17.8% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 6,943 shares of the company’s stock worth $1,075,000 after buying an additional 1,051 shares during the last quarter. Finally, Vident Advisory LLC raised its position in shares of Astera Labs by 25.8% during the 4th quarter. Vident Advisory LLC now owns 9,841 shares of the company’s stock valued at $1,637,000 after buying an additional 2,021 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.